副鼻腔炎に対するPazufloxacinの基礎的・臨床的検討

  • 大山 勝
    Department of Otorhinolaryngology, Faculty of Medicine, Kagoshima University
  • 松崎 勉
    Department of Otorhinolaryngology, Faculty of Medicine, Kagoshima University
  • 古田 茂
    Department of Otorhinolaryngology, Faculty of Medicine, Kagoshima University
  • 大野 文夫
    Department of Otorhinolaryngology, Faculty of Medicine, Kagoshima University
  • 出口 浩二
    Department of Otorhinolaryngology, Faculty of Medicine, Kagoshima University
  • 原口 兼明
    Department of Otorhinolaryngology, Faculty of Medicine, Kagoshima University
  • 上野 員義
    Department of Otorhinolaryngology, Faculty of Medicine, Kagoshima University
  • 島 哲也
    Department of Otorhinolaryngology, Faculty of Medicine, Kagoshima University
  • 土器屋 富美子
    Department of Otorhinolaryngology, Faculty of Medicine, Kagoshima University
  • 市川 銀一郎
    Department of Otorhinolaryngology, Schoool of Medicine, Juntendo University
  • 山川 卓也
    Department of Otorhinolaryngology, Schoool of Medicine, Juntendo University
  • 桜井 淳
    Department of Otorhinolaryngology, Schoool of Medicine, Juntendo University
  • 板橋 隆嗣
    Department of Otorhinolaryngology, Koto Hospital
  • 和田 昌士
    Department of Otorhinolaryngology, Tokyo Rousai Hospital
  • 渡辺 洋
    Department of Otorhinolaryngology, Taketani Hospital
  • 三宅 浩郷
    Department of Otorhinolaryngology, Tokai University, Tokyo. Hospital
  • 佐藤 むつみ
    Department of Otorhinolaryngology, Tokai University, Tokyo. Hospital
  • 高橋 秀明
    Department of Otorhinolaryngology, Tokai University, Tokyo. Hospital
  • 山崎 充代
    Department of Otorhinolaryngology, Tokai University, Tokyo. Hospital
  • 坂井 真
    Department of Otorhinolaryngology, School of Medicine, Tokai University
  • 新川 敦
    Department of Otorhinolaryngology, School of Medicine, Tokai University
  • 木村 栄成
    Department of Otorhinolaryngology, School of Medicine, Tokai University
  • 秋田谷 直
    Department of Otorhinolaryngology, Tokai University, Oiso Hospital
  • 宮本 ゆう子
    Department of Otorhinolaryngology, Tokai University, Oiso Hospital
  • 藤井 一省
    Department of Otorhinolaryngology, Nihon Kohkan Hospital
  • 福里 博
    Department of Otorhinolaryngology, Nihon Kohkan Hospital
  • 小川 裕
    Department of Otorhinolaryngology, KoseiHospital
  • 加賀 達美
    Department of Otorhinolaryngology, KoseiHospital
  • 馬場 駿吉
    Department of Otorhinolaryngology, School of Medicine, Nagoya City University
  • 宮本 直哉
    Department of Otorhinolaryngology, School of Medicine, Nagoya City University
  • 横田 明
    Department of Otorhinolaryngology, Kawanishi Municipal Hospital
  • 伊藤 弘美
    Department of Otorhinolaryngology, Kawanishi Municipal Hospital
  • 小林 武弘
    Department of Otorhinolaryngology, Nagoya City Higashi General Hospital
  • 伊佐治 弘子
    Department of Otorhinolaryngology, Nagoya City Higashi General Hospital
  • 甕 久人
    Department of Otorhinolaryngology, Kasugai City Hospital
  • 柘植 勇人
    Department of Otorhinolaryngology, Kasugai City Hospital
  • 森部 一穂
    Department of Otorhinolaryngology, Kasugai City Hospital
  • 小島 憲
    Department of Otorhinolaryngology, Kasugai City Hospital
  • 亀井 壮太郎
    Department of Otorhinolaryngology, Kasugai City Hospital
  • 笠島 哲也
    Department of Otorhinolaryngology, Toyohashi City Hospital
  • 小関 晶嗣
    Department of Otorhinolaryngology, Toyohashi City Hospital
  • 松永 亨
    Department of Otorhinolaryngology, Koseiren Kamo Hospital
  • 阪上 雅史
    Department of Otorhinolaryngology, Koseiren Kamo Hospital
  • 土井 勝美
    Department of Otorhinolaryngology, Koseiren Kamo Hospital
  • 久保 武
    Department of Otorhinolaryngology, Koseiren Kamo Hospital
  • 荻野 仁
    Department of Otorhinolaryngology, School of Medicine, Osaka University
  • 島田 久美
    Department of Otorhinolaryngology, School of Medicine, Osaka University
  • 芦田 健太郎
    Department of Otorhinolaryngology, Otemae Hospital
  • 村田 潤子
    Department of Otorhinolaryngology, Otemae Hospital
  • 佐々木 良二
    Department of Otorhinolaryngology, Kinki Chuou Hospital
  • 深澤 啓二郎
    Department of Otorhinolaryngology, Kinki Chuou Hospital
  • 杉井 亜也子
    Department of Otorhinolaryngology, Kinki Chuou Hospital
  • 原田 康夫
    Department of Otorhinolaryngology, School of Medicine, Hiroshima University
  • 鈴木 衛
    Department of Otorhinolaryngology, School of Medicine, Hiroshima University
  • 平川 勝洋
    Department of Otorhinolaryngology, School of Medicine, Hiroshima University
  • 工田 昌也
    Department of Otorhinolaryngology, School of Medicine, Hiroshima University
  • 夜陣 紘治
    Department of Otorhinolaryngology, Hiroshima Red Cross Hospital & Atomic Bomb Survivors Hospital
  • 平田 思
    Department of Otorhinolaryngology, Hiroshima Red Cross Hospital & Atomic Bomb Survivors Hospital
  • 田頭 宣治
    Department of Otorhinolaryngology, Hiroshima General Hospital
  • 柿 音高
    Department of Otorhinolaryngology, Yoshida General Hospital
  • 小林 優子
    Department of Otorhinolaryngology, Hiroshima Mitsubishi Hospital
  • 津田 哲也
    Department of Otorhinolaryngology, Mitsubishi Mihara Hospital
  • 廣田 常治
    Department of Otorhinolaryngology, Kagoshima Prefectural Kanoya Hospital
  • 岩淵 康雄
    Department of Otorhinolaryngology, Kagoshima Prefectural Kanoya Hospital
  • 徳重 栄一郎
    Department of Otorhinolaryngology, Kagoshima Prefectural Kanoya Hospital
  • 内薗 明裕
    Department of Otorhinolaryngology, Kagoshima City Hospital
  • 渡辺 荘郁
    Department of Otorhinolaryngology, Kagoshima City Hospital
  • 松村 益美
    Department of Otorhinolaryngology, Kagoshima Prefectural Hokusatsu Hospital
  • 村野 健三
    Department of Otorhinolaryngology, Kagoshima Prefectural Hokusatsu Hospital
  • 宮崎 康博
    Department of Otorhinolaryngology, Kagoshima Prefectural Hokusatsu Hospital

書誌事項

タイトル別名
  • Fundamental and clinical studies on efficacy of Pazufloxacin for sinusitis

この論文をさがす

抄録

新しか経口キノロン系抗菌剤pazufloxacin (PZFX) の副鼻腔炎に対する有効性と安全性を評価する目的で鼻粘膜などの組織内移行および多施設統一プロトコールによる一般臨床試験を行い, 以下の成績を得た.<BR>1. PZFXは上顎洞粘膜, 上顎洞貯留液, 節骨洞粘膜および鼻茸への良好な移行を示した.<BR>2. 臨床効果判定をなし得た45例に対する有効率は, 本剤1回100mgまたは200mgを1日2~3回の投与で急性副鼻腔炎に対し83%, 慢性副鼻腔炎急性増悪症に対し80%, 全体で82%であった.<BR>3. X線所見の改善度につかて検討し得た37例に対する改善率は65%であつた.<BR>4. 単独菌感染の菌消失率はグラム陽性菌で82%, グラム陰性菌で100%であり, 複数菌感染例を含め全体で78%であった.<BR>5. 副作用は51例中1例も認められなかった. また, 臨床検査値異常としては好酸球増多および単球増多が各1例に認められたが, いずれも軽度であった. 以上の成績から, PZFXは副鼻腔炎に対し1日300~600mg投与により高か有用性の得られる薬剤であると考えられた.

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ